Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Marshall, Claire [1 ]
Littlewood, Zoe [1 ]
Herety, Nichola [1 ]
Heal, Calvin [2 ]
Sharif, Jennifer [1 ]
Clayton, Tim [1 ]
机构：
[1] Salford Royal NHS Fdn Trust, Manchester, Lancs, England
[2] Univ Manchester, Ctr Biostat, Manchester, Lancs, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
PA03
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [1] Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data
    Ferrucci, Silvia M.
    Maronese, Carlo A.
    Tavecchio, Simona
    Angileri, Luisa
    Genovese, Giovanni
    Marzano, V. Angelo
    [J]. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2022, 157 (02) : 211 - 213
  • [2] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kim, Nicole S.
    Maliyar, Khalad
    Oliveira, Luciana
    O'Toole, Ashley
    Gooderham, Melinda J.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
  • [3] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    [J]. DERMATOLOGY, 2024, 240 (02) : 337 - 342
  • [4] A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Potestio, Luca
    Fontanella, Giuseppina
    Picone, Vincenzo
    Bennardo, Luigi
    Scalvenzi, Massimiliano
    Patruno, Cataldo
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [5] Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
    Stingeni, L.
    Bianchi, L.
    Antonelli, E.
    Caroppo, E. S.
    Ferrucci, S. M.
    Ortoncelli, M.
    Fabbrocini, G.
    Nettis, E.
    Schena, D.
    Napolitano, M.
    Gola, M.
    Bonzano, L.
    Rossi, M.
    Fortina, A. Belloni
    Balato, A.
    Peris, K.
    Foti, C.
    Guarneri, F.
    Romanelli, M.
    Patruno, C.
    Savoia, P.
    Fargnoli, M. C.
    Russo, F.
    Errichetti, E.
    Bianchelli, T.
    Bianchi, L.
    Pellacani, G.
    Feliciani, C.
    Offidani, A.
    Corazza, M.
    Micali, G.
    Milanesi, N.
    Malara, G.
    Chiricozzi, A.
    Tramontana, M.
    Hansel, K.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1292 - 1299
  • [6] A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis
    Stingeni, Luca
    Bianchi, Leonardo
    Antonelli, Elettra
    Caroppo, Elena Sofia
    Ferrucci, Silvia Mariel
    Gurioli, Carlotta
    Ortoncelli, Michela
    Fabbrocini, Gabriella
    Nettis, Eustachio
    Schena, Donatella
    Napolitano, Maddalena
    Gola, Massimo
    Bonzano, Laura
    Rossi, MariaTeresa
    Belloni Fortina, Anna
    Balato, Anna
    Peris, Ketty
    Foti, Caterina
    Guarneri, Fabrizio
    Romanelli, Marco
    Patruno, Cataldo
    Savoia, Paola
    Esposito, Maria
    Russo, Filomena
    Errichetti, Enzo
    Bianchelli, Tommaso
    Bianchi, Luca
    Pellacani, Giovanni
    Feliciani, Claudio
    Offidani, Annamaria
    Corazza, Monica
    Micali, Giuseppe
    Milanesi, Nicola
    Malara, Giovanna
    Chiricozzi, Andrea
    Tramontana, Marta
    Hansel, Katharina
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E384 - E388
  • [7] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
    Peng, Cong
    Cao, Qiaozhi
    Xiong, Feng
    Xu, Hui
    Li, Jie
    [J]. MEDCOMM, 2024, 5 (10):
  • [8] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Salman, Andac
    Sengun, Ozlem Apti
    Aktas, Meryem
    Taskapan, Oktay
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (01)
  • [9] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    [J]. JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [10] Real-world experience of dupilumab for patients with moderate-to-severe atopic dermatitis in a tertiary care setting
    Kreeshan, F. C.
    Lavery, D.
    Clarke, S.
    Warren, R. B.
    Hunter, H. J. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 70 - 70
12345